Mick Mellor-Clark joins us from PathoQuest, where he was Chief Commercial Officer. In this role, he has led the definition and execution of a new commercial strategy for the company – driving a renewed focus on GMP biosafety testing and driving the success of this company.

Prior to PathoQuest, Mick was at BioReliance (a leading CRO in biologics biosafety and analytical testing) for 20 years. In that time, the company grew from a start-up based in Glasgow to a strategic business unit and global brand as part of Merck KGaA. Whilst at BioReliance, Mick drove change and growth for the organisation. He developed and led functions including Strategic Partnership Accounts, Global Key Accounts, European Sales and Asia Pacific Sales. 

Mick started his career in Commercial Development at Inveresk Research (now Charles River Tranent). He holds an Honours Degree in Molecular Biology from the University of Edinburgh, and has completed the General Management Program at the Cranfield School of Management.